For example, the approach has identified novel oncogenic drivers by infecting Eμ-Myc HSPCs with libraries of shRNAs followed by transplantation into normal recipients and monitoring for tumor onset (Scuoppoet al. 2012). This evidence concerns the gene MYC and neoplasm.